Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Fusion Pharmaceuticals Inc (NQ: FUSN ) 21.55 UNCHANGED Last Price Updated: 4:00 PM EDT, Jun 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 21.55 Bid (Size) 21.65 (33) Ask (Size) 21.87 (1) Prev. Close 21.55 Today's Range 21.55 - 21.55 52wk Range 2.310 - 21.60 Shares Outstanding 63,846,009 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN May 09, 2024 From Kahn Swick & Foti, LLC Via Business Wire FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q1 2024 May 07, 2024 FUSN stock results show that Fusion Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Performance YTD +160.27% +160.27% 1 Month N/A N/A 3 Month +0.47% +0.47% 6 Month +70.36% +70.36% 1 Year +565.12% +565.12% More News Read More Top 4 Health Care Stocks That May Plunge This Month April 26, 2024 Via Benzinga Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market April 25, 2024 Via Investor's Business Daily Recap: Fusion Pharmaceuticals Q4 Earnings March 20, 2024 Via Benzinga Unveiling 11 Analyst Insights On Fusion Pharmaceuticals March 20, 2024 Via Benzinga Kuehn Law Encourages FUSN, KAMN, DRQ, and VZIO Investors to Contact Law Firm March 19, 2024 Via News Direct AstraZeneca Hikes Annual Dividend By 7% Just Before Vote On Its CEO's Pay Package Boost April 11, 2024 Via Benzinga Exposures Product Safety AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race April 02, 2024 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN) April 01, 2024 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE) March 25, 2024 From Brodsky & Smith LLC Via GlobeNewswire FUSN Stock Earnings: Fusion Pharmaceuticals Misses EPS for Q4 2023 March 20, 2024 Via InvestorPlace FUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Fusion Pharmaceuticals Inc. - FUSN March 19, 2024 From Kahn Swick & Foti, LLC Via Business Wire Nasdaq Turns Higher; Caleres Posts Upbeat Q4 Results March 19, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session March 19, 2024 Via Benzinga Dow Jumps 200 Points; Core & Main Shares Gain After Q4 Results March 19, 2024 Via Benzinga Topics Stocks Exposures US Equities BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Whole Earth Brands, Inc. (Nasdaq – FREE), Kinnate Biopharma Inc. (Nasdaq – KNTE), Societal CDMO Check Corp. (Nasdaq – March 19, 2024 From Brodsky & Smith LLC Via GlobeNewswire National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday March 19, 2024 Via Benzinga Topics Stocks Exposures US Equities Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) Records 52-Week High Tuesday Morning March 19, 2024 Via Investor Brand Network Nasdaq Down 100 Points; US Housing Starts Surge In February March 19, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 19, 2024 Via Benzinga Fusion Pharma Stock Nearly Doubles After Scoring $2 Billion AstraZeneca Takeover March 19, 2024 Via Investor's Business Daily Why Is Greenwave Tech Solutions (GWAV) Stock Down 53% Today? March 19, 2024 Via InvestorPlace Nvidia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday March 19, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.